Popular
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
CME/CEReady, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD
Stephen J. Greene, MD
Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
Dermatology Hub: Neuroimmune NetworkHypopigmentation in Atopic Dermatitis Patients with Skin of Color
Cheri Frey, MD
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
Programs
Ambulatory Monitoring Approaches for PSVT: Which One and When?
MinuteCE®Ambulatory Monitoring Approaches for PSVT: Which One and When?
Jennifer Carlquist, PA-C
Brian P. Rose, PA-C, MPH, AACC
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
- CME/CE In-Person & Virtual Event
Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona Disease Deep Dive: The Evolving Role of Nonsteroidal Topical Therapy for Atopic Dermatitis
Practical DermatologyDisease Deep Dive: The Evolving Role of Nonsteroidal Topical Therapy for Atopic Dermatitis
Walter Liszewski, MD
Adelaide Hebert, MD
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Jennifer Caudle, DO, FACOFP
Greg Mattingly, MD
Clinical Practice
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Diabetes and EndocrinologyFINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CEHypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
Dolores Shoback, MD
Michael T. Collins, MD
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
CardiologyAPOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
MinuteCE®Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
MinuteCE®Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Natalie S. Callander, MD
Doctors Lounge
Humanoids in Healthcare: Extending the Reach of Surgical Expertise
The ConvergenceHumanoids in Healthcare: Extending the Reach of Surgical Expertise
Brian P. McDonough, MD, FAAFP
Michael Yip, PhD
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Jean-Claude Saghbini
Engaging Patients and Caregivers About Digital Therapeutics
Medical Industry FeatureEngaging Patients and Caregivers About Digital Therapeutics
Charles Turck, PharmD, BCPS, BCCCP
Maggie Emerson, DNP, APRN, PMHNP-BC
Bruno Batinica, MD
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
The Convergence"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
MAPSChatsInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
Matt Birnholz, MD
Brandon Young, PhD
CME
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Komal Jhaveri, MD, FACP
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Jennifer Carlquist, PA-C
Brian P. Rose, PA-C, MPH, AACC
PSVT Management: Suboptimal Care Is Too Frequent
MinuteCE®PSVT Management: Suboptimal Care Is Too Frequent
Brian P. Rose, PA-C, MPH, AACC
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Industry Feature
Helping Patients Stay on Track With Collaborative LDL-C Care
Medical Industry FeatureHelping Patients Stay on Track With Collaborative LDL-C Care
Barry D. Bertolet MD, FACC
Todd Sandroni PharmD
Understanding Obesity: From Adiposity to Multi-Organ Impact
Medical Industry FeatureUnderstanding Obesity: From Adiposity to Multi-Organ Impact
Robert F. Kushner, MD
A Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Medical Industry FeatureA Real-World CIDP Patient Journey: Perspectives From a Neuromuscular Specialist
Shiv Bhadola, MD
ADHD with Comorbid Anxiety: What Clinicians Need to Know
Innovations In MedicineADHD with Comorbid Anxiety: What Clinicians Need to Know
Ann Childress, MD
Jeffrey Strawn, MD
The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial
Project Oncology®The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial
Jennifer Caudle, DO, FACOFP
Nicole Lamanna, MD
Putting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
Innovations In MedicinePutting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer